Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain

Zhengjiang Qian,Hongchao Li,Haiyang Yang,Qin Yang,Zhonghua Lu,Liping Wang,Ying Chen,Xiang Li

DOI: https://doi.org/10.1126/sciadv.abi5811

IF: 13.6

2021-10-22

Science Advances

Abstract:Osteocalcin regulating oligodendrocyte myelination is mediated by GPR37, a novel receptor for osteocalcin in the CNS.

multidisciplinary sciences

What problem does this paper attempt to address?

Induction of Oligodendrocyte Differentiation by Olig2 and Sox10: Evidence for Reciprocal Interactions and Dosage-Dependent Mechanisms.

Zijing Liu,Xuemei Hu,Jun Cai,Ben Liu,Xiaozhong Peng,Michael Wegner,Mengsheng Qiu

DOI: https://doi.org/10.1016/j.ydbio.2006.10.007

IF: 3.148

2006-01-01

Developmental Biology

Abstract:Recent studies have suggested that oligodendrocyte development is likely to be under the control of a hierarchy of lineage-specific transcription factors. In the developing mouse spinal cord, expression of Olig2, Sox10 and Nkx2.2 is sequentially up-regulated in cells of oligodendrocyte lineage. These transcription factors play essential roles in oligodendrocyte specification and differentiation. However, the regulatory relationship and functional interactions among these transcription factors have not been determined. In this study, we systematically investigated the function and hierarchical relationship of Olig2, Sox10 and Nkx2.2 transcription factors in the control of oligodendrocyte differentiation. It was found that over-expression of Olig2 is sufficient to induce Sox10, Nkx2.2 and precocious oligodendrocyte differentiation in embryonic chicken spinal cord. Sox10 expression alone is also sufficient to stimulate ectopic oligodendrocyte differentiation and weakly induce Nkx2.2 expression. Although genetic evidence indicated that Sox10 functions downstream of Olig2, Sox10 activity can modulate Olig2 expression. In addition, we presented evidence that the control of oligodendrocyte differentiation by Olig2, Sox10 and Nkx2.2 is a dosage-dependent developmental process and can be affected by both haploinsufficiency and over-dosage.
Osteocalcin Alleviates Lipopolysaccharide-Induced Acute Inflammation via Activation of GPR37 in Macrophages

Zhengjiang Qian,Chunhua Liu,Hongchao Li,Haiyang Yang,Jianhao Wu,Jing Liu,Yanjiao Li,Xuhui Chen,Jianyang Xu,Xiang Li

DOI: https://doi.org/10.3390/biomedicines10051006

IF: 4.757

2022-04-28

Biomedicines

Abstract:The G protein-coupled receptor 37 (GPR37) has been reported to be expressed in macrophages and the activation of GPR37 by its ligand/agonist, and it can regulate macrophage-associated functions and inflammatory responses. Since our previous work identified that osteocalcin (OCN) acts as an endogenous ligand for GPR37 and can elicit various intracellular signals by interacting with GPR37, we thus hypothesized that OCN may also play a functional role in macrophage through the activation of GPR37. To verify the hypothesis, we conducted a series of in vivo and in vitro studies in lipopolysaccharide (LPS)-challenged mice and primary cultured macrophages. Our results reveal that the OCN gene deletion (OCN−/−) and wild type (WT) mice showed comparable death rates and inflammatory cytokines productions in response to a lethal dose of LPS exposure. However, the detrimental effects caused by LPS were significantly ameliorated by exogenous OCN treatments in both WT and OCN−/− mice. Notably, the protective effects of OCN were absent in GPR37−/− mice. In coordination with the in vivo results, our in vitro studies further illustrated that OCN triggered intracellular responses via GPR37 in peritoneal macrophages by regulating the release of inflammatory factors and macrophage phagocytic function. Finally, we exhibited that the adoptive transfer of OCN-treated macrophages from WT mice significantly inhibits the release of pro-inflammatory cytokines in GPR37−/− mice exposed to LPS. Taken together, these findings suggest a protective role of OCN against LPS-caused acute inflammation, by the activation of GPR37 in macrophages, and provide a potential application of the activation of the OCN/GPR37 regulatory axis as a therapeutic strategy for inflammatory diseases.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
The myelination‐associated G protein‐coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation

Antonia L. Schmidt,Marco Kremp,Takaaki Aratake,Siying Cui,Yifeng Lin,Xiaowen Zhong,Q. Richard Lu,Chengfu Zhang,Mengsheng Qiu,Tim Aberle,Michael Wegner

DOI: https://doi.org/10.1002/glia.24530

2024-03-30

Glia

Abstract:Main Points Ectopic Zfp488 and Nkx2.2 influence oligodendroglial gene expression. Gpr37 is a transcriptional target of both Zfp488 and Nkx2.2 in differentiating oligodendrocytes. Zfp488 and Nkx2.2 act in concert with Sox10 to activate Gpr37 expression. Oligodendrocyte differentiation and myelination in the central nervous system are controlled and coordinated by a complex gene regulatory network that contains several transcription factors, including Zfp488 and Nkx2.2. Despite the proven role in oligodendrocyte differentiation little is known about the exact mode of Zfp488 and Nkx2.2 action, including their target genes. Here, we used overexpression of Zfp488 and Nkx2.2 in differentiating CG4 cells to identify aspects of the oligodendroglial expression profile that depend on these transcription factors. Although both transcription factors are primarily described as repressors, the detected changes argue for an additional function as activators. Among the genes activated by both Zfp488 and Nkx2.2 was the G protein‐coupled receptor Gpr37 that is important during myelination. In agreement with a positive effect on Gpr37 expression, downregulation of the G protein‐coupled receptor was observed in Zfp488‐ and in Nkx2.2‐deficient oligodendrocytes in the mouse. We also identified several potential regulatory regions of the Gpr37 gene. Although Zfp488 and Nkx2.2 both bind to one of the regulatory regions downstream of the Gpr37 gene in vivo, none of the regulatory regions was activated by either transcription factor alone. Increased activation by Zfp488 or Nkx2.2 was only observed in the presence of Sox10, a transcription factor continuously present in oligodendroglial cells. Our results argue that both Zfp488 and Nkx2.2 also act as transcriptional activators during oligodendrocyte differentiation and cooperate with Sox10 to allow the expression of Gpr37 as a modulator of the myelination process.

neurosciences
G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination

Changqing Lu,Lihua Dong,Hui Zhou,Qianmei Li,Guojiao Huang,Shu Jun Bai,Linchuan Liao

DOI: https://doi.org/10.1038/s41598-018-22452-0

2018-03-14

Abstract:Oligodendrocytes are the myelin-producing cells of the central nervous system (CNS). A variety of brain disorders from "classical" demyelinating diseases, such as multiple sclerosis, stroke, schizophrenia, depression, Down syndrome and autism, are shown myelination defects. Oligodendrocyte myelination is regulated by a complex interplay of intrinsic, epigenetic and extrinsic factors. Gpr17 (G protein-coupled receptor 17) is a G protein-coupled receptor, and has been identified to be a regulator for oligodendrocyte development. Here, we demonstrate that the absence of Gpr17 enhances remyelination in vivo with a toxin-induced model whereby focal demyelinated lesions are generated in spinal cord white matter of adult mice by localized injection of LPC(L-a-lysophosphatidylcholine). The increased expression of the activated form of Erk1/2 (phospho-Erk1/2) in lesion areas suggested the potential role of Erk1/2 activity on the Gpr17-dependent modulation of myelination. The absence of Gpr17 enhances remyelination is correlate with the activated Erk1/2 (phospho-Erk1/2).Being a membrane receptor, Gpr17 represents an ideal druggable target to be exploited for innovative regenerative approaches to acute and chronic CNS diseases.
A GPR17-cAMP-Lactate Signaling Axis in Oligodendrocytes Regulates Whole-Body Metabolism

Zhimin Ou,Yanchen Ma,Yuxia Sun,Gege Zheng,Shiyun Wang,Rui Xing,Xiang Chen,Ying Han,Jiajia Wang,Q. Richard Lu,Tong-Jin Zhao,Ying Chen

DOI: https://doi.org/10.1016/j.celrep.2019.02.060

IF: 8.8

2019-01-01

Cell Reports

Abstract:The CNS plays a pivotal role in energy homeostasis, but whether oligodendrocytes are involved has been largely unexplored. Here, we show that signaling through GPR17, a G-protein-coupled receptor predominantly expressed in the oligodendrocyte lineage, regulates food intake by modulating hypothalamic neuronal activities. GPR17-null mice and mice with an oligodendrocyte-specific knockout of GPR17 have lean phenotypes on a high-fat diet, suggesting that GPR17 regulates body weight by way of oligodendrocytes. Downregulation of GPR17 results in activation of cAMP-protein kinase A (PKA) signaling in oligodendrocytes and upregulated expression of pyruvate dehydrogenase kinase 1 (PDK1), which promotes lactate production. Elevation of lactate activates AKT and STAT3 signaling in the hypothalamic neurons, leading to increased expression of Pomc and suppression of Agrp. Our findings uncover a critical role of oligodendrocytes in metabolic homeostasis, where GPR17 modulates the production of lactate, which, in turn, acts as a metabolic signal to regulate neuronal activity.
GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke

Sharon Owino,Michelle M Giddens,Jessie G Jiang,TrangKimberly T Nguyen,Fu Hung Shiu,Trisha Lala,Marla Gearing,Myles R McCrary,Xiaohuan Gu,Ling Wei,Shan P Yu,Randy A Hall,Michelle M. Giddens,Jessie G. Jiang,TrangKimberly T. Nguyen,Myles R. McCrary,Shan P. Yu,Randy A. Hall

DOI: https://doi.org/10.1016/j.expneurol.2021.113719

IF: 5.62

2021-08-01

Experimental Neurology

Abstract:The generation of neural stem and progenitor cells following injury is critical for the function of the central nervous system, but the molecular mechanisms modulating this response remain largely unknown. We have previously identified the G protein-coupled receptor 37 (GPR37) as a modulator of ischemic damage in a mouse model of stroke. Here we demonstrate that GPR37 functions as a critical negative regulator of progenitor cell dynamics and gliosis following ischemic injury. In the central nervous system, GPR37 is enriched in mature oligodendrocytes, but following injury we have found that its expression is dramatically increased within a population of Sox2-positive progenitor cells. Moreover, the genetic deletion of GPR37 did not alter the number of mature oligodendrocytes following injury but did markedly increase the number of both progenitor cells and injury-induced Olig2-expressing glia. Alterations in the glial environment were further evidenced by the decreased activation of oligodendrocyte precursor cells. These data reveal that GPR37 regulates the response of progenitor cells to ischemic injury and provides new perspectives into the potential for manipulating endogenous progenitor cells following stroke.

neurosciences
Stage-Specific Regulation Of Oligodendrocyte Development By Hedgehog Signaling In The Spinal Cord

Xiaofeng Xu,Qian Yu,Minxi Fang,Min Yi,Aifen Yang,Binghua Xie,Junlin Yang,Zunyi Zhang,Zhongmin Dai,Mengsheng Qiu

DOI: https://doi.org/10.1002/glia.23729

2020-01-01

Glia

Abstract:Elucidation of signaling pathways that control oligodendrocyte (OL) development is a prerequisite for developing novel strategies for myelin repair in neurological diseases. Despite the extensive work outlining the importance of Hedgehog (Hh) signaling in the commitment and generation of OL progenitor cells (OPCs), there are conflicting reports on the role of Hh signaling in regulating OL differentiation and maturation. In the present study, we systematically investigated OPC specification and differentiation in genetically modified mouse models of Smoothened (Smo), an essential component of the Hh signaling pathway in vertebrates. Through conditional gain-offunction strategy, we demonstrated that hyperactivation of Smo in neural progenitors induced transient ectopic OPC generation and precocious OL differentiation accompanied by the co-induction of Olig2 and Nkx2.2. After the commitment of OL lineage, Smo activity is not required for OL differentiation, and sustained expression of Smo in OPCs stimulated cell proliferation but inhibited terminal differentiation. These findings have uncovered the stage-specific regulation of OL development by Smo-mediated Hh signaling, providing novel insights into the molecular regulation of OL differentiation and myelin repair.
C1ql1 expression in oligodendrocyte progenitor cells promotes oligodendrocyte differentiation

Zeynep M. Altunay,Joyshree Biswas,Hiu W. Cheung,Robert S. Pijewski,Lucille E. Papile,Yetunde O. Akinlaja,Andrew Tang,Lyndsay C. Kresic,Alexander D. Schouw,Maksym V. Ugrak,Keaven Caro,Perla A. Peña Palomino,Susanne Ressl,Akiko Nishiyama,Stephen J. Crocker,David C. Martinelli

DOI: https://doi.org/10.1111/febs.17256

2024-09-11

FEBS Journal

Abstract:Myelinating oligodendrocytes arise from oligodendrocyte progenitor cells (OPCs). How OPCs are instructed to differentiate is poorly understood. The C1QL family has been studied for their functions at neuron–neuron synapses, but we show that OPCs express C1ql1. We show that bidirectional modulation of C1ql1 regulates the production of oligodendrocytes and myelin during recovery from demyelination. This suggests that C1QL1 may initiate a previously unrecognized signaling pathway to promote differentiation of oligodendrocytes. Myelinating oligodendrocytes arise from the stepwise differentiation of oligodendrocyte progenitor cells (OPCs). Approximately 5% of all adult brain cells are OPCs. Why would a mature brain need such a large number of OPCs? New myelination is possibly required for higher‐order functions such as cognition and learning. Additionally, this pool of OPCs represents a source of new oligodendrocytes to replace those lost during injury, inflammation, or in diseases such as multiple sclerosis (MS). How OPCs are instructed to differentiate into oligodendrocytes is poorly understood, and for reasons presently unclear, resident pools of OPCs are progressively less utilized in MS. The complement component 1, q subcomponent‐like (C1QL) protein family has been studied for their functions at neuron–neuron synapses, but we show that OPCs express C1ql1. We created OPC‐specific conditional knockout mice and show that C1QL1 deficiency reduces the differentiation of OPCs into oligodendrocytes and reduces myelin production during both development and recovery from cuprizone‐induced demyelination. In vivo over‐expression of C1QL1 causes the opposite phenotype: increased oligodendrocyte density and myelination during recovery from demyelination. We further used primary cultured OPCs to show that C1QL1 levels can bidirectionally regulate the extent of OPC differentiation in vitro. Our results suggest that C1QL1 may initiate a previously unrecognized signaling pathway to promote differentiation of OPCs into oligodendrocytes. This study has relevance for possible novel therapies for demyelinating diseases and may illuminate a previously undescribed mechanism to regulate the function of myelination in cognition and learning.

biochemistry & molecular biology
New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3β signaling

Jiajia Lu,Xiaojian Shi,Qiang Fu,Yaguang Han,Lei Zhu,Zhibin Zhou,Yongchuan Li,Nan Lu

DOI: https://doi.org/10.1186/s11658-024-00614-5

2024-07-08

Abstract:Objective: Osteoporosis is a global health issue characterized by decreased bone mass and microstructural degradation, leading to an increased risk of fractures. This study aims to explore the molecular mechanism by which P2X7 receptors influence osteoclast formation and bone resorption through the PI3K-Akt-GSK3β signaling pathway. Methods: An osteoporosis mouse model was generated through ovariectomy (OVX) in normal C57BL/6 and P2X7f/f; LysM-cre mice. Osteoclasts were isolated for transcriptomic analysis, and differentially expressed genes were selected for functional enrichment analysis. Metabolite analysis was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS), and multivariate statistical analysis and pattern recognition were used to identify differential lipid metabolism markers and their distribution. Bioinformatics analyses were conducted using the Encyclopedia of Genes and Genomes database and the MetaboAnalyst database to assess potential biomarkers and create a metabolic pathway map. Osteoclast precursor cells were used for in vitro cell experiments, evaluating cell viability and proliferation using the Cell Counting Kit 8 (CCK-8) assay. Osteoclast precursor cells were induced to differentiate into osteoclasts using macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-beta ligand (RANKL), and tartrate-resistant acid phosphatase (TRAP) staining was performed to compare differentiation morphology, size, and quantity between different groups. Western blot analysis was used to assess the expression of differentiation markers, fusion gene markers, and bone resorption ability markers in osteoclasts. Immunofluorescence staining was employed to examine the spatial distribution and quantity of osteoclast cell skeletons, P2X7 protein, and cell nuclei, while pit assay was used to evaluate osteoclast bone resorption ability. Finally, in vivo animal experiments, including micro computed tomography (micro-CT), hematoxylin and eosin (HE) staining, TRAP staining, and immunohistochemistry, were conducted to observe bone tissue morphology, osteoclast differentiation, and the phosphorylation level of the PI3K-Akt-GSK3β signaling pathway. Results: Transcriptomic and metabolomic data collectively reveal that the P2X7 receptor can impact the pathogenesis of osteoporosis through the PI3K-Akt-GSK3β signaling pathway. Subsequent in vitro experiments showed that cells in the Sh-P2X7 + Recilisib group exhibited increased proliferative activity (1.15 versus 0.59), higher absorbance levels (0.68 versus 0.34), and a significant increase in resorption pit area (13.94 versus 3.50). Expression levels of osteoclast differentiation-related proteins MMP-9, CK, and NFATc1 were markedly elevated (MMP-9: 1.72 versus 0.96; CK: 2.54 versus 0.95; NFATc1: 3.05 versus 0.95), along with increased fluorescent intensity of F-actin rings. In contrast, the OE-P2X7 + LY294002 group showed decreased proliferative activity (0.64 versus 1.29), reduced absorbance (0.34 versus 0.82), and a significant decrease in resorption pit area (5.01 versus 14.96), accompanied by weakened expression of MMP-9, CK, and NFATc1 (MMP-9: 1.14 versus 1.79; CK: 1.26 versus 2.75; NFATc1: 1.17 versus 2.90) and decreased F-actin fluorescent intensity. Furthermore, in vivo animal experiments demonstrated that compared with the wild type (WT) + Sham group, mice in the WT + OVX group exhibited significantly increased levels of CTX and NTX in serum (CTX: 587.17 versus 129.33; NTX: 386.00 versus 98.83), a notable decrease in calcium deposition (19.67 versus 53.83), significant reduction in bone density, increased trabecular separation, and lowered bone mineral density (BMD). When compared with the KO + OVX group, mice in the KO + OVX + recilisib group showed a substantial increase in CTX and NTX levels in serum (CTX: 503.50 versus 209.83; NTX: 339.83 versus 127.00), further reduction in calcium deposition (29.67 versus 45.33), as well as decreased bone density, increased trabecular separation, and reduced BMD. Conclusion: P2X7 receptors positively regulate osteoclast formation and bone resorption by activating the PI3K-Akt-GSK3β signaling pathway.
Specification and maintenance of oligodendrocyte precursor cells from neural progenitor cells: involvement of microRNA-7a.

Xianghui Zhao,Jiang Wu,Minhua Zheng,Fang Gao,Gong Ju

DOI: https://doi.org/10.1091/mbc.E12-04-0270

2012-01-01

Molecular Biology of the Cell

Abstract:The generation of myelinating cells from multipotential neural stem cells in the CNS requires the initiation of specific gene expression programs in oligodendrocytes (OLs). We reasoned that microRNAs (miRNAs) could play an important role in this process by regulating genes crucial for OL development. Here we identified miR-7a as one of the highly enriched miRNAs in oligodendrocyte precursor cells (OPCs), overexpression of which in either neural progenitor cells (NPCs) or embryonic mouse cortex promoted the generation of OL lineage cells. Blocking the function of miR-7a in differentiating NPCs led to a reduction in OL number and an expansion of neuronal populations simultaneously. We also found that overexpression of this miRNA in purified OPC cultures promoted cell proliferation and inhibited further maturation. In addition, miR-7a might exert the effects just mentioned partially by directly repressing proneuronal differentiation factors including Pax6 and NeuroD4, or proOL genes involved in oligodendrocyte maturation. These results suggest that miRNA pathway is essential in determining cell fate commitment for OLs and thus providing a new strategy for modulating this process in OL loss diseases.
Osteocalcin-expressing neutrophils from skull bone marrow exert immunosuppressive and neuroprotective effects after TBI

Jiabo Li,Hao Wang,Pengjiao Ma,Tao Li,Jiakui Ren,Jingyu Zhang,Mi Zhou,Yuhang He,Teng Yang,Wenhui He,Man-Tian Mi,Yang-Wuyue Liu,Shuang-Shuang Dai

DOI: https://doi.org/10.1016/j.celrep.2024.114670

IF: 8.8

2024-08-31

Cell Reports

Abstract:Li et al. demonstrate that OCN-expressing Nskull infiltrates brain tissue quickly and persistently after TBI. The transcription factor FosL1 governs specific gene expressions, including OCN, CCRL2, Arg1, and BDNF, and, combined with GAPDHlow-associated metabolic reprogramming, endows Nskull with antiapoptotic, proliferative and chemotactic capabilities, immunosuppressive effects on Nblood, and neurological protection in TBI.

cell biology
GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation

Liang Zhou,Chong-Yu Shao,Si-min Xu,Jiao Ma,Ya-Jun Xie,Lin Zhou,Peng Teng,Yin Wang,Mengsheng Qiu,Ying Shen

DOI: https://doi.org/10.1007/s12035-014-8678-9

IF: 5.682

2014-01-01

Molecular Neurobiology

Abstract:Oligodendrocytes are generated by the differentiation and maturation of oligodendrocyte precursor cells (OPCs). The failure of OPC differentiation is a major cause of demyelinating diseases; thus, identifying the molecular mechanisms that affect OPC differentiation is critical for understanding the myelination process and repairing after demyelination. Although prevailing evidence shows that OPC differentiation is a highly coordinated process controlled by multiple extrinsic and intrinsic factors, such as growth factors, axon signals, and transcription factors, the intracellular signaling in OPC differentiation is still unclear. Here, we showed that glycogen synthase kinase 3β (GSK3β) is an essential positive modulator of OPC differentiation. Both pharmacologic inhibition and knockdown of GSK3β remarkably suppressed OPC differentiation. Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assays and Ki67 staining showed that the effect of GSK3β on OPC differentiation was not via cell death. Conversely, activated GSK3β was sufficient to promote OPC differentiation. Our results also demonstrated that the transcription of myelin genes was regulated by GSK3β inhibition, accompanying accumulated nuclear β-catenin, and reduced the expression of transcriptional factors that are relevant to the expression of myelin genes. Taken together, our study identified GSK3β as a profound positive regulator of OPC differentiation, suggesting that GSK3β may contribute to the inefficient regeneration of oligodendrocytes and myelin repair after demyelination.
Loss of GPR37 Increases Susceptibility to Demyelination

Brilee M. Coleman,Fengqiao Li,Michelle M. Giddens,Randy A. Hall

DOI: https://doi.org/10.1096/fasebj.30.1_supplement.709.1

2016-04-01

The FASEB Journal

Abstract:GPR37 is an orphan G protein‐coupled receptor that is highly expressed in the brain. Previous work has shown that GPR37 is a receptor for the secreted neuroprotective and glioprotective factor prosaposin and that prosaposin acts through GPR37 to protect cultured astrocytes from oxidative stress‐induced cell death (Meyer et al., Proc. Natl. Acad. USA, 2013). Furthermore, it has previously been shown that prosaposin enhances the survival of oligodendroglia in vitro and also promotes myelination in vivo (Hiraiwa et al., Proc. Natl. Acad. Sci. USA, 1997; Hiraiwa et al., Glia, 1999). Interestingly, several reports indicate that GPR37 is expressed at particularly high levels in oligodendrocytes (Imai et al., Cell, 2001; Cahoy et al., J. Neurosci., 2008). However, despite the aforementioned evidence for GPR37 expression in oligodendroglia, the role(s) that GPR37 may play in oligodendroglial biology remain uncharacterized. Here we show that GPR37‐knockout (GPR37‐KO) mice display more rapid and extensive demyelination than their wild type (WT) counterparts in the cuprizone model of demyelination. Furthermore, we observed that GPR37‐KO mice do not show an increased loss of oligodendrocyte precursor cells or mature oligodendrocytes. Parallel studies on primary cultures of oligodendrocytes also revealed a protective role for GPR37. From these data, we conclude that loss of GPR37 alters oligodendrocyte physiology and increases susceptibility to demyelination, independent of effects on oligodendrocyte proliferation or differentiation. The present work identifies GPR37 as a potential drug target for the treatment of demyelinating diseases such as multiple sclerosis. Ongoing studies in this area seek to elucidate the signaling pathways downstream of GPR37 that regulate oligodendrocyte physiology and support myelination. Support or Funding Information This research was supported through the Fast Forward program of the National Multiple Sclerosis Society.

cell biology,biochemistry & molecular biology,biology
Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament

Xiao Liu,Lei Zhang,Ge Wang,Wei Zhao,Chen Liang,Youzhi Tang,Yenan Fu,Bo Liu,Jing Zhang,Xiaoguang Liu,Hongquan Zhang,Yu Yu

DOI: https://doi.org/10.1007/s11684-024-1075-5

2024-10-25

Frontiers of Medicine

Abstract:Ossification of the posterior longitudinal ligament (OPLL) is a condition comprising ectopic bone formation from spinal ligaments. This disease is a leading cause of myelopathy in the Asian population. However, the molecular mechanism underlying OPLL and efficient preventive interventions remain unclear. Here, we performed single-cell RNA sequencing and revealed that type I interferon (IFN) signaling was activated in the ossified ligament of patients with OPLL. We also observed that IFN-β stimulation promoted the osteogenic differentiation of preosteoblasts in vitro and activated the ossification-related gene SPP1 , thereby confirming the single-cell RNA sequencing findings. Further, blocking the IFN-α/β subunit 1 receptor (IFNAR1) using an anti-IFNAR1 neutralizing antibody markedly suppressed osteogenic differentiation. Together, these results demonstrated that the type I IFN signaling pathway facilitated ligament ossification, and the blockade of this signaling might provide a foundation for the prevention of OPLL.

oncology,medicine, research & experimental
Primary Osteocyte Supernatants Metabolomic Profiling of Two Transgenic Mice With Connexin43 Dominant Negative Mutants

Meng Chen,Guobin Li,Lan Zhang,Kaiting Ning,Baoqiang Yang,Jean X. Jiang,Dong-En Wang,Huiyun Xu

DOI: https://doi.org/10.3389/fendo.2021.649994

IF: 6.055

2021-05-18

Frontiers in Endocrinology

Abstract:Osteocytes could release some small molecules (≤ 1 kDa) through gap junctions and hemichannels to extracellular environment, such as prostaglandin E2 (PGE2), nitric oxide (NO) and adenosine triphosphate (ATP), which play key roles in transferring signals between bone cells and other tissue cells. Connexin (Cx) 43 is the most abundant connexin in osteocytes. To further discover molecules released by osteocytes through Cx43 channels and better understand the regulatory function of Cx43 channels in osteocytes, we performed non-targeted global metabolomics analysis using liquid chromatography-tandem mass spectrometry (LC-MS/MS) on conditioned medium collected from osteocytes isolated from two transgenic mouse models with Cx43 dominant negative mutants driven by a 10 kb-DMP1 promoter: R76W (gap junctions are blocked, whereas hemichannels are promoted) and Δ130-136 (both gap junctions and hemichannels are blocked). The results revealed that several new categories of molecules, such as “fatty acyls” and “carboxylic acids and derivatives”, could be released through osteocytic Cx43 channels. In addition, alteration of Cx43 channel function affected the release of metabolites related to inflammatory reaction and oxidative stress. Pathway analysis further showed that citric acid cycle was the most differential metabolic pathway regulated by Cx43 channels. In sum, these results isolated new potential metabolites released by osteocytes through Cx43 channels, and offered a novel perspective to understand the regulatory mechanisms of osteocytes on themselves and other cells as well.

endocrinology & metabolism
Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer's Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia

Chang Shan,Deng Zhang,Dong-Ni Ma,Yan-Fang Hou,Qian-Qian Zhuang,Yan-Ling Gong,Li-Hao Sun,Hong-Yan Zhao,Bei Tao,Yu-Ying Yang,Sheng-Tian Li,Jian-Min Liu

DOI: https://doi.org/10.1038/s41420-023-01343-y

2023-02-06

Abstract:Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by the accumulation of amyloid β peptides (Aβ) and impaired glucose metabolism in the brain. Osteocalcin (OCN), an osteoblast-derived protein, has been shown to modulate brain functions but whether it has any effect on AD is undetermined. In this study, daily intraperitoneal injection of OCN for 4 weeks ameliorated the anxiety-like behaviors and cognitive dysfunctions in the APP/PS1 transgenic AD mice model, as shown in the increased entries into the central area in open field test, the increased time and entries into open arms in elevated plus maze test, the increased time spent in the light chamber in light-dark transition test, as well as the reduced escape latency and the increased preference for target quadrant in Morris water maze test. Aβ burden in the hippocampus and cortex of AD mice was ameliorated by OCN. Besides, OCN improved the neural network function of the brain, mainly in the enhanced power of high gamma band in the medial prefrontal cortex of AD mice. The proliferation of astrocytes in the hippocampus in AD mice was also inhibited by OCN as demonstrated by immunofluorescence. Furthermore, OCN enhanced glycolysis in astrocytes and microglia, as evidenced by elevated glucose consumption, lactate production, and increased extracellular acidification rate. Such an effect was abolished when the receptor of OCN - Gpr158 was knockdown in astrocytes. Our study revealed OCN as a novel therapeutic factor for AD potentially through reducing Aβ burden and upregulation of glycolysis in neuroglia.
Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption

Keisha M. Cawley,Nancy Cecile Bustamante-Gomez,Anveshi G. Guha,Ryan S. MacLeod,Jinhu Xiong,Igor Gubrij,Yu Liu,Robin Mulkey,Michela Palmieri,Jeff D. Thostenson,Joseph J. Goellner,Charles A. O’Brien

DOI: https://doi.org/10.1016/j.celrep.2020.108052

IF: 8.8

2020-09-01

Cell Reports

Abstract:Osteoprotegerin (OPG) inhibits the ability of receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) to stimulate the differentiation, activity, and survival of bone-resorbing osteoclasts. Genetic studies in mice show that osteocytes are an important source of RANKL, but the cellular sources of OPG are unclear. We use conditional deletion of Tnfrsf11b, which encodes OPG, from different cell populations to identify functionally relevant sources of OPG in mice. Deletion from B lymphocytes and osteocytes, two cell types commonly thought to supply OPG, has little or no impact on bone mass. By contrast, deletion of Tnfrsf11b from osteoblasts increases bone resorption and reduces bone mass to an extent similar to germline deletion, demonstrating that osteoblasts are an essential source of OPG. These results suggest that, in addition to producing new bone matrix, osteoblasts also play an active role in terminating the resorption phase of the bone remodeling cycle by suppressing RANKL activity.

cell biology
Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a

Hailong Wang,Jinqiao Li,Zihan Xu,Feng Wu,Hongyu Zhang,Chao Yang,Jian Chen,Bai Ding,Xiukun Sui,Zhifeng Guo,Yinghui Li,Zhongquan Dai

DOI: https://doi.org/10.7717/peerj.10898

IF: 3.061

2021-03-02

PeerJ

Abstract:Osteocalcin (OCN) was the most abundant noncollagen protein and considered as an endocrine factor. However, the functions of Undercarboxylated osteocalcin (ucOCN) on osteoclast and bone resorption are not well understood. In the present study, preosteoclast RAW264.7 cells and bone marrow mononuclear cells (BMMs) were treated with ucOCN purified from prokaryotic bacteria. Our results showed that ucOCN attenuated the proliferation of RAW264.7 cells with a concentration dependant manner by MTS assay. Scrape wounding assay revealed the decreased motility of RAW264.7 cells after ucOCN treatment. RT-qPCR results manifested the inhibitory effects of ucOCN on the expression of osteoclastic marker genes in RAW264.7 cells during inducing differentiation of RANKL. It was also observed that ucOCN inhibited the formation of multinucleated cells from RAW264.7 cells and BMMs detected by TRAP staining. The number and area of bone resorb pits were also decreased after treatment with ucOCN during their osteoclast induction by toluidine blue staining. The formation and integrity of the osteoclast actin ring were impaired by ucOCN by immunofluorescent staining. Time dependant treatment of ucOCN during osteoclastic induction demonstrated the inhibitory effects mainly occurred at the early stage of osteoclastogenesis. Signaling analysis of luciferase activity of the CRE or SRE reporter and ERK1/2 phosphorylation showed the selective inhibitor or siRNA of Gprc6a (a presumptive ucOCN receptor) could attenuate the promotion of ucOCN on CRE-luciferase activity. Taken together, we provided the first evidence that ucOCN had negative effects on the early differentiation and bone resorption of osteoclasts via Gprc6a.

multidisciplinary sciences
OPALIN is an LGI1 receptor promoting oligodendrocyte differentiation

Xiao-Yu Teng,Ping Hu,Cai-Ming Zhang,Qin-Xin Zhang,Guolin Yang,Yan-Yu Zang,Zhi-Xiong Liu,Guiquan Chen,Yun Stone Shi

DOI: https://doi.org/10.1073/pnas.2403652121

2024-08-06

Abstract:Leucine-rich glioma-inactivated protein 1 (LGI1), a secretory protein in the brain, plays a critical role in myelination; dysfunction of this protein leads to hypomyelination and white matter abnormalities (WMAs). Here, we hypothesized that LGI1 may regulate myelination through binding to an unidentified receptor on the membrane of oligodendrocytes (OLs). To search for this hypothetic receptor, we analyzed LGI1 binding proteins through LGI1-3 × FLAG affinity chromatography with mouse brain lysates followed by mass spectrometry. An OL-specific membrane protein, the oligodendrocytic myelin paranodal and inner loop protein (OPALIN), was identified. Conditional knockout (cKO) of OPALIN in the OL lineage caused hypomyelination and WMAs, phenocopying LGI1 deficiency in mice. Biochemical analysis revealed the downregulation of Sox10 and Olig2, transcription factors critical for OL differentiation, further confirming the impaired OL maturation in Opalin cKO mice. Moreover, virus-mediated re-expression of OPALIN successfully restored myelination in Opalin cKO mice. In contrast, re-expression of LGI1-unbound OPALIN_K23A/D26A failed to reverse the hypomyelination phenotype. In conclusion, our study demonstrated that OPALIN on the OL membrane serves as an LGI1 receptor, highlighting the importance of the LGI1/OPALIN complex in orchestrating OL differentiation and myelination.
CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways

Minglian Xu,Dezhi Song,Xiaoxiao Xie,Yiwu Qin,Jian Huang,Chaofeng Wang,Junchun Chen,Yuangang Su,Jiake Xu,Jinmin Zhao,Qian Liu

DOI: https://doi.org/10.1016/j.isci.2023.107760

IF: 5.8

2023-08-01

iScience

Abstract:Osteoporosis is a prevalent systemic metabolic disease in modern society, in which patients often suffer from bone loss due to over-activation of osteoclasts. Currently, amelioration of bone loss through modulation of osteoclast activity is a major therapeutic strategy. Ataxia telangiectasia mutated (ATM) inhibitor CGK733 (CG) was reported to have a sensitizing impact in treating malignancies. However, its effect on osteoporosis remains unclear. In this study, we investigated the effects of CG on osteoclast differentiation and function, as well as the therapeutic effects of CG on osteoporosis. Our study found that CG inhibits osteoclast differentiation and function. We further found that CG inhibits the activation of NFATc1 and ultimately osteoclast formation by inhibiting RANKL-mediated Ca2+ oscillation and the NF-κB/MAPK signaling pathway. Next, we constructed an ovariectomized mouse model and demonstrated that CG improved bone loss in ovariectomized mice. Therefore, CG may be a potential drug for the prevention and treatment of osteoporosis.

multidisciplinary sciences

Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain

Induction of Oligodendrocyte Differentiation by Olig2 and Sox10: Evidence for Reciprocal Interactions and Dosage-Dependent Mechanisms.

Osteocalcin Alleviates Lipopolysaccharide-Induced Acute Inflammation via Activation of GPR37 in Macrophages

The myelination‐associated G protein‐coupled receptor 37 is regulated by Zfp488, Nkx2.2, and Sox10 during oligodendrocyte differentiation

G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination

A GPR17-cAMP-Lactate Signaling Axis in Oligodendrocytes Regulates Whole-Body Metabolism

GPR37 modulates progenitor cell dynamics in a mouse model of ischemic stroke

Stage-Specific Regulation Of Oligodendrocyte Development By Hedgehog Signaling In The Spinal Cord

C1ql1 expression in oligodendrocyte progenitor cells promotes oligodendrocyte differentiation

New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3β signaling

Specification and maintenance of oligodendrocyte precursor cells from neural progenitor cells: involvement of microRNA-7a.

Osteocalcin-expressing neutrophils from skull bone marrow exert immunosuppressive and neuroprotective effects after TBI

GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation

Loss of GPR37 Increases Susceptibility to Demyelination

Single-cell transcriptome profiling identifies the activation of type I interferon signaling in ossified posterior longitudinal ligament

Primary Osteocyte Supernatants Metabolomic Profiling of Two Transgenic Mice With Connexin43 Dominant Negative Mutants

Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer's Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption

Undercarboxylated osteocalcin inhibits the early differentiation of osteoclast mediated by Gprc6a

OPALIN is an LGI1 receptor promoting oligodendrocyte differentiation

CGK733 alleviates ovariectomy-induced bone loss through blocking RANKL-mediated Ca2+ oscillations and NF-κB/MAPK signaling pathways